media

Markets

Market Nav

RATIO ANALYSIS

You can view the ratio analysis for the last 5 years.
Orchid Pharma Ltd.
ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
PER SHARE RATIOS     
      
Basic EPS (Rs.)11.35-0.48-28.55-14.757.80
Diluted EPS (Rs.)11.35-0.48-28.55-14.757.80
Cash EPS (Rs.)25.3021.71-1.87-1.2622.41
Book Value[Excl.RevalReserv]/Share (Rs.)168.72158.61159.96250.97-79.14
Book Value[Incl.RevalReserv]/Share (Rs.)168.72158.61159.96250.97-79.14
Revenue From Operations / Share (Rs.)163.14137.09110.26124.4767.44
PBDIT / Share (Rs.)25.2515.2215.93-0.24-0.14
PBIT / Share (Rs.)11.82-6.10-10.76-31.09-14.75
PBT / Share (Rs.)13.54-13.94-23.34-32.117.80
Net Profit / Share (Rs.)11.880.38-28.55-32.117.80
NP After MI And SOA / Share (Rs.)11.35-0.47-28.55-32.117.80
      
PROFITABILITY RATIOS     
      
PBDIT Margin (%)15.4711.1014.44-0.19-0.21
PBIT Margin (%)7.24-4.44-9.75-24.98-21.87
PBT Margin (%)8.29-10.16-21.16-25.7911.56
Net Profit Margin (%)7.270.28-25.89-25.7911.56
NP After MI And SOA Margin (%)6.95-0.34-25.89-25.7911.56
Return on Networth / Equity (%)6.72-0.30-17.84-12.79-9.85
Return on Capital Employeed (%)5.65-2.86-4.00-8.23-17.88
Return On Assets (%)3.78-0.17-9.41-7.612.25
Long Term Debt / Equity (X)0.210.320.650.48-2.02
Total Debt / Equity (X)0.480.410.650.48-3.01
Asset Turnover Ratio (%)0.570.470.300.210.19
      
LIQUIDITY RATIOS     
      
Current Ratio (X)1.351.873.873.250.29
Quick Ratio (X)0.731.152.792.390.22
Inventory Turnover Ratio (X)2.022.091.601.441.43
      
COVERAGE RATIOS     
      
Interest Coverage Ratio (%)3.201.941.27-0.23-4.26
Interest Coverage Ratio (Post Tax) (%)1.50-0.77-0.85-30.52-437.99
      
VALUATION RATIOS     
      
Enterprise Value (Cr.)1869.701420.3010472.28346.981842.00
EV / Net Operating Revenue (X)2.812.5423.270.683.07
EV / EBITDA (X)18.1422.86161.10-350.31-1442.21
MarketCap / Net Operating Revenue (X)2.362.0722.360.040.07
Price / BV (X)2.281.7915.410.02-0.06
Price / Net Operating Revenue (X)2.362.0722.360.040.07
EarningsYield0.020.00-0.01-6.121.46
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
PER SHARE RATIOS 
Basic EPS (Rs.)11.35
Diluted EPS (Rs.)11.35
Cash EPS (Rs.)25.30
Book Value[Excl.RevalReserv]/Share (Rs.)168.72
Book Value[Incl.RevalReserv]/Share (Rs.)168.72
Revenue From Operations / Share (Rs.)163.14
PBDIT / Share (Rs.)25.25
PBIT / Share (Rs.)11.82
PBT / Share (Rs.)13.54
Net Profit / Share (Rs.)11.88
NP After MI And SOA / Share (Rs.)11.35
PROFITABILITY RATIOS 
PBDIT Margin (%)15.47
PBIT Margin (%)7.24
PBT Margin (%)8.29
Net Profit Margin (%)7.27
NP After MI And SOA Margin (%)6.95
Return on Networth / Equity (%)6.72
Return on Capital Employeed (%)5.65
Return On Assets (%)3.78
Long Term Debt / Equity (X)0.21
Total Debt / Equity (X)0.48
Asset Turnover Ratio (%)0.57
LIQUIDITY RATIOS 
Current Ratio (X)1.35
Quick Ratio (X)0.73
Inventory Turnover Ratio (X)2.02
COVERAGE RATIOS 
Interest Coverage Ratio (%)3.20
Interest Coverage Ratio (Post Tax) (%)1.50
VALUATION RATIOS 
Enterprise Value (Cr.)1869.70
EV / Net Operating Revenue (X)2.81
EV / EBITDA (X)18.14
MarketCap / Net Operating Revenue (X)2.36
Price / BV (X)2.28
Price / Net Operating Revenue (X)2.36
EarningsYield0.02